Sign Up to like & get
recommendations!
1
Published in 2017 at "OncoTargets and therapy"
DOI: 10.2147/ott.s130236
Abstract: Purpose Malignant pheochromocytoma (PCC) is a rare tumor with a very poor prognosis and no effective treatments. The aim of this study was to assess the efficacy of a novel second-generation synthetic heat-shock protein 90…
read more here.
Keywords:
malignant pheochromocytoma;
vitro vivo;
vivo;
hsp90 inhibitor ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.847556
Abstract: New targeted chemotherapy agents greatly improved five-year survival in NSCLC patients, but which were susceptible to drug resistance. NVP-AUY922, terminated in phase II clinical trials, exhibited promising anti-NSCLC (non-small-cell lung cancer) activity targeting to Hsp90N…
read more here.
Keywords:
hsp90n;
nvp auy922;
complex crystal;
auy922 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.861266
Abstract: As overexpression and membrane localization of stress proteins together with high lactate levels promote radioresistance in tumor cells, we studied the effect of the Hsp90 inhibitor NVP-AUY922 on the cytosolic and membrane expression of heat…
read more here.
Keywords:
tumor cells;
membrane hsp70;
membrane;
nvp auy922 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Oncology Letters"
DOI: 10.3892/ol.2022.13222
Abstract: The present study examined the radiosensitization induced by a heat shock protein 90 inhibitor, N-vinylpyrrolidone (NVP)-AUY922, in CD133-positive cells in a hypoxic area of T98G spheroids. CD133-positive cells that are induced in the hypoxic microenvironment…
read more here.
Keywords:
radiosensitization;
nvp auy922;
cancer stem;
cd133 positive ... See more keywords